- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloma in South Africa
Total 506 results
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Center for International Blood and Marrow Transplant...National Marrow Donor Program; Pediatric Blood and Marrow Transplant Consortium and other collaboratorsCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States, Canada, Puerto Rico, Australia
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Therapy-Related Acute Myeloid LeukemiaUnited States
-
AbbVieGenentech, Inc.; Celgene CorporationWithdrawnMultiple MyelomaUnited States, Australia, Canada, Spain
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Southwest Oncology GroupNational Cancer Institute (NCI)Terminated
-
National Cancer Institute (NCI)Suspended
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
Janssen Research & Development, LLCCompletedLeukemia, Myeloid, AcuteUnited States, Australia, France, Poland, Taiwan, Belgium, Germany, United Kingdom, Spain, Israel, Turkey, Korea, Republic of, Russian Federation, Sweden
-
AbbVieTerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Australia, Germany, Israel, Italy, Japan, Spain
-
Astellas Pharma Global Development, Inc.Active, not recruitingLeukemia, Acute Myeloid (AML)Japan, United States, Belgium, Canada, France, Germany, Israel, Italy, Korea, Republic of, Poland, Spain, Taiwan, Turkey, United Kingdom
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaKorea, Republic of, United States, Spain, Belgium, Germany, Czechia, Hungary, Taiwan, France, Israel, Italy, United Kingdom, Australia, Austria, Poland, Luxembourg
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveUnited States, Canada, Australia, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
AmgenCompletedEnd-stage Renal Disease | Relapsed Multiple MyelomaUnited States, Australia, Canada
-
zr Pharma & GmbHCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMelanoma | Lymphoma | Multiple Myeloma | Pancreatic Cancer | Non-Small Cell Lung CancerAustralia
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Fungal Infection | Neutropenia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission | Recurrent Childhood Acute Myeloid... and other conditionsUnited States, Canada, Puerto Rico
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Australia, Canada, Italy, Norway, Spain, Sweden, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)United States, Spain, Belgium, Germany, Japan, Taiwan, Turkey, Italy, Australia, Austria, Switzerland, Israel, Bulgaria, France, Norway, Brazil, Poland, Portugal, Czechia, Argentina
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
AbbVieGenentech, Inc.TerminatedAcute Myelogenous Leukemia | Myelogenous Leukemia | Treatment Naive AMLUnited States, Australia, France, Germany
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
Bristol-Myers SquibbCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis PharmaceuticalsActive, not recruitingLeukemiaUnited States, Canada
-
PfizerActive, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Multiple MyelomaUnited States
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
University of UlmRecruitingAcute Myeloid Leukemia (AML) | Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)Austria, Germany
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Untreated Adult Acute Myeloid LeukemiaUnited States, Canada
-
Seagen Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, Netherlands
-
PfizerCompletedAdvanced Multiple MyelomaGermany, United States, Spain, United Kingdom, Belgium, Canada, France, Greece
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | LeukemiaHong Kong, Canada, Belgium, France, Spain, Taiwan, United States, Australia, Czechia, Hungary, Italy, Israel, Japan, Korea, Republic of, Germany, China, Ukraine, Romania, Argentina, Croatia, Brazil, Serbia, Russian Federation, Portugal, Bulgari... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
Human Genome Sciences Inc.CompletedMultiple MyelomaUnited States, Canada, Australia, India
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
Vion PharmaceuticalsCompletedLeukemiaFrance, Canada, Greece, United States, Belgium, Netherlands, United Kingdom, Germany, Poland, Serbia
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Poland, Greece, Australia, Sweden
-
Seagen Inc.Genentech, Inc.CompletedMultiple MyelomaUnited States